We are live on ! Find out more
OQS

Occudo Quantitative Strategies Portfolio holdings

AUM $1.84B
1-Year Est. Return 22.15%
This Fund
S&P 500
This Quarter Est. Return
-20.16%
1 Year Est. Return
+22.15%
3 Year Est. Return
+67.4%
5 Year Est. Return
+61.87%
10 Year Est. Return
–
AUM
$1.22B
AUM Growth
+$25.2M
Cap. Flow
+$287M
Cap. Flow %
23.51%
Top 10 Hldgs %
5.22%
Holding
1,483
New
378
Increased
381
Reduced
313
Closed
382

Top Buys

Rank Stock Value
1
ASAN icon
Asana
ASAN
+$8.41M
2
MRVL icon
Marvell Technology
MRVL
+$8.25M
3
GFS icon
GlobalFoundries
GFS
+$7.98M
4
NFLX icon
Netflix
NFLX
+$7.87M
5
ZBRA icon
Zebra Technologies
ZBRA
+$7.48M

Top Sells

Rank Stock Value
1
MMM icon
3M
MMM
+$6.39M
2
TTD icon
Trade Desk
TTD
+$6.28M
3
XYL icon
Xylem
XYL
+$6.22M
4
GILD icon
Gilead Sciences
GILD
+$6.21M
5
UAA icon
Under Armour
UAA
+$6.18M

Sector Composition

Rank Sector Weight
1 Technology 21.57%
2 Healthcare 15.01%
3 Industrials 12.49%
4 Financials 12.17%
5 Consumer Discretionary 12.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HOOK
1051
DELISTED
HOOKIPA Pharma
HOOK
$62K 0.01%
3,799
-61
-2% -$1.01K
ATNX
1052
DELISTED
Athenex, Inc. Common Stock
ATNX
$62K 0.01%
7,599
– –
DAKT icon
1053
Daktronics
DAKT
$955M
$61K 0.01%
20,351
+7,539
+59% +$25.2K
LSAK icon
1054
Lesaka Technologies
LSAK
$396M
$61K 0.01%
11,843
– –
STTK icon
1055
Shattuck Labs
STTK
$675M
$60K ﹤0.01%
14,862
-10,079
-40% -$36.5K
CDZI icon
1056
Cadiz
CDZI
$251M
$59K ﹤0.01%
25,371
-14,145
-36% -$29.5K
VTEX icon
1057
VTEX
VTEX
$735M
$59K ﹤0.01%
+19,191
New +$92.6K
BRLT icon
1058
Brilliant Earth
BRLT
$17.1M
$58K ﹤0.01%
+12,278
New +$77.1K
IMRX icon
1059
Immuneering
IMRX
$267M
$57K ﹤0.01%
+10,498
New +$56K
LVO icon
1060
LiveOne
LVO
$61.7M
$57K ﹤0.01%
6,624
– –
RAIL icon
1061
FreightCar America
RAIL
$261M
$56K ﹤0.01%
15,486
+2,681
+21% +$12.8K
VIRX
1062
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$56K ﹤0.01%
14,450
-5,155
-26% -$14.7K
SIEN
1063
DELISTED
Sientra, Inc.
SIEN
$55K ﹤0.01%
6,610
+4
+0.1% +$55
PLSE icon
1064
Pulse Biosciences
PLSE
$2.43B
$54K ﹤0.01%
58,383
+39,981
+217% +$101K
CTSO icon
1065
Cytosorbents Corp
CTSO
$22.7M
$53K ﹤0.01%
24,367
+6,092
+33% +$14K
ARQ icon
1066
Arq
ARQ
$84.6M
$53K ﹤0.01%
11,392
-55
-0.5% -$299
EVLO
1067
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$53K ﹤0.01%
1,267
-44
-3% -$2.04K
BYSI icon
1068
BeyondSpring
BYSI
$47.3M
$52K ﹤0.01%
36,074
+483
+1% +$806
ICAD
1069
DELISTED
iCAD Inc
ICAD
$52K ﹤0.01%
+12,961
New +$49.4K
TNGX icon
1070
Tango Therapeutics
TNGX
$4.43B
$50K ﹤0.01%
+11,075
New +$67.1K
ITI
1071
DELISTED
Iteris, Inc.
ITI
$50K ﹤0.01%
17,444
-1,055
-6% -$2.93K
BDTX icon
1072
Black Diamond Therapeutics
BDTX
$96.8M
$49K ﹤0.01%
19,807
-7,316
-27% -$17K
KLRS
1073
Kalaris Therapeutics
KLRS
$83.5M
$48K ﹤0.01%
+532
New +$55.8K
KORE
1074
DELISTED
KORE Group Holdings
KORE
$47K ﹤0.01%
+3,031
New +$67.6K
BCEL
1075
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$47K ﹤0.01%
26,313
-2,529
-9% -$5.29K
41 42
43
44 45

Similar funds

RP
Regal Partners Sydney, NSW, Australia $1.84B AUM 54.78% 1-Year Est. Return
ABTD
Arvest Bank Trust Division Dewey, Oklahoma $1.84B AUM 20.84% 1-Year Est. Return
KAM
Kensington Asset Management Austin, Texas $1.84B AUM 13.95% 1-Year Est. Return
FCIM
Fairview Capital Investment Management Greenbrae, California $1.84B AUM 13.39% 1-Year Est. Return
CPSAC
Chas P. Smith & Associates (CPS) Lakeland, Florida $1.84B AUM 13.62% 1-Year Est. Return
WIC
Willis Investment Counsel Gainesville, Georgia $1.83B AUM 15.78% 1-Year Est. Return
OFS
OneAscent Financial Services Birmingham, Alabama $1.85B AUM 18.45% 1-Year Est. Return
LOAME
Lombard Odier Asset Management (Europe) London, United Kingdom $1.85B AUM 27.05% 1-Year Est. Return

Occudo Quantitative Strategies's Q2 2022 Portfolio in Review

As of Q2 2022, Occudo Quantitative Strategies held 1,483 positions worth $1.22B, up 2.1% from $1.19B the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.

Occudo Quantitative Strategies deployed $287M of net new capital in Q2 2022, opening 378 new positions and adding to 381 existing holdings. Its largest new stake was Marvell Technology: 145,519 shares worth $6.33M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Sherwin-Williams, an estimated $5.12M trimmed.

  • Occudo Quantitative Strategies's largest Q2 2022 buy was Marvell Technology: 145,519 shares worth $6.33M.
  • Occudo Quantitative Strategies added most to Asana in Q2 2022, an estimated $8.41M increase.
  • Occudo Quantitative Strategies's biggest Q2 2022 reduction was Sherwin-Williams, cutting an estimated $5.12M.
  • Occudo Quantitative Strategies fully exited 3M in Q2 2022, selling an estimated $6.39M.
  • Occudo Quantitative Strategies's ten largest holdings make up 5.2% of its $1.22B portfolio in Q2 2022.
  • Occudo Quantitative Strategies opened 378 new positions and closed 382 in Q2 2022.
  • Occudo Quantitative Strategies's portfolio value rose 2.1% quarter-over-quarter to $1.22B.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2022, filed 15 Aug 2022.